6734 Stock Overview
iXensor Co., Ltd. provides technology platform that turns smartphones into in vitro diagnostic devices through its smart color sensing technology for connected healthcare.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
iXensor Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$6.10 |
| 52 Week High | NT$12.00 |
| 52 Week Low | NT$4.89 |
| Beta | 0.52 |
| 1 Month Change | -26.68% |
| 3 Month Change | -28.99% |
| 1 Year Change | -44.29% |
| 3 Year Change | -72.58% |
| 5 Year Change | n/a |
| Change since IPO | -82.27% |
Recent News & Updates
Shareholder Returns
| 6734 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | -20.5% | -2.1% | -2.1% |
| 1Y | -44.3% | 2.0% | 27.5% |
Return vs Industry: 6734 underperformed the TW Medical Equipment industry which returned 2% over the past year.
Return vs Market: 6734 underperformed the TW Market which returned 27.5% over the past year.
Price Volatility
| 6734 volatility | |
|---|---|
| 6734 Average Weekly Movement | 6.4% |
| Medical Equipment Industry Average Movement | 4.4% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 8.3% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6734's share price has been volatile over the past 3 months.
Volatility Over Time: 6734's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | Carson Chen | www.ixensor.com |
iXensor Co., Ltd. provides technology platform that turns smartphones into in vitro diagnostic devices through its smart color sensing technology for connected healthcare. The company’s PixoTest technology uses the lighting and image sensing module of the smartphone to detect the color change reaction on the immunoassay or colorimetric strip. It offers PixoTest Blood Glucose Monitoring System and PixoTest POCT System for chronic diseases management; Eveline Smart Fertility System and Eveline Care Telehealth Platform for women’s health management; and PixoTest COVID-19 Rapid Antigen Test for infectious disease management, as well as PixoHealth Pass Admin app and Web portal.
iXensor Co., Ltd. Fundamentals Summary
| 6734 fundamental statistics | |
|---|---|
| Market cap | NT$334.63m |
| Earnings (TTM) | -NT$51.66m |
| Revenue (TTM) | NT$37.33m |
9.0x
P/S Ratio-6.5x
P/E RatioIs 6734 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6734 income statement (TTM) | |
|---|---|
| Revenue | NT$37.33m |
| Cost of Revenue | NT$24.89m |
| Gross Profit | NT$12.44m |
| Other Expenses | NT$64.10m |
| Earnings | -NT$51.66m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.94 |
| Gross Margin | 33.32% |
| Net Profit Margin | -138.40% |
| Debt/Equity Ratio | 16.1% |
How did 6734 perform over the long term?
See historical performance and comparison